Back to News
Market Impact: 0.15

Agree To Buy Exelon At $37, Earn 4.3% Using Options

EXCCLSDEQXNDAQ
Futures & OptionsDerivatives & VolatilityCompany FundamentalsCapital Returns (Dividends / Buybacks)Analyst InsightsMarket Technicals & Flows
Agree To Buy Exelon At $37, Earn 4.3% Using Options

Selling a June 2026 put option for Exelon Corp (EXC) with a $37 strike price offers a 4% annualized return, exceeding EXC's 3.7% dividend yield based on its current $43.20 share price; however, this strategy only provides upside if the option is exercised, requiring a 14.3% price decline. While buying EXC shares for the dividend exposes investors to similar downside risk, the predictability of EXC's dividend, coupled with its 20% trailing twelve-month volatility, should be considered when evaluating the risk-reward profile of selling the put.

Analysis

The analysis focuses on an options strategy for Exelon Corp (EXC), specifically selling a June 2026 put option with a $37 strike price. This strategy offers an annualized return of 4%, derived from the $1.60 premium received, which notably exceeds Exelon's current 3.7% annualized dividend yield, based on its share price of $43.20. However, the put seller only participates in EXC's upside by acquiring shares if the stock price declines by 14.3% to the $37 strike price, leading to an effective cost basis of $35.40 per share before commissions. While purchasing shares directly at $43.20 to capture the dividend exposes investors to a similar downside threshold (a 14.29% drop to reach $37), it allows for participation in any share price appreciation. The article highlights Exelon's trailing twelve-month volatility of 20%, a crucial factor when assessing the probability of the stock reaching the strike price. Furthermore, it underscores the importance of evaluating the sustainability of Exelon's dividend, as dividend payments are generally tied to company profitability and are not guaranteed.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo